Form D · Other
Forma Therapeutics Holdings LLC
Watertown, MA · CIK 0001538927
Offering snapshot reported Sep 6, 2012 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 29, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 6, 2012 | Initial | $10,000,000 | No comparison | 2 | SEC filing |
| Jan 17, 2012 | Initial | $50,053,000 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-183750
Source: Form D, filed Sep 6, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Reinhard Ambros, Ph.D. | Director |
| Alexis Borisy | Director |
| Peter Finn | Executive |
| Michael A. Foley | Director |
| Steven Hall | Director |
| Andrew Littlehale | Executive |
| Thong Yuen Poon | Director |
| Steven Tregay, Ph.D. | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
500 Arsenal Street Suite 100
Watertown, MA, 02472
Watertown, MA, 02472